Introduction: Breast neoplasms rank among the leading causes of disease-related mortality in women, with predominant risk factors including family history, hormonal imbalances, obesity, excessive alcohol intake and a sedentary lifestyle. Due to its complexity, treatment often involves a multidisciplinary approach and technological advancements have improved breast cancer detection and diagnosis, although, despite these improvements, mortality rates remain concerning. Therefore, analyzing the epidemiological profile of breast cancer in Pará is crucial for monitoring trends and developing targeted strategies aimed at reducing mortality in this region. Objectives: Analyze the epidemiological profile of mortality due to malignant breast neoplasms during the years 2018 to 2023 in the state of Pará. Methods: This is an ecological time-series study. Secondary data on malignant breast neoplasms (ICD-10 C50) were obtained from the Department of Information Technology of the Unified Health System (DATASUS), via the Mortality Information System (SIM), referring to the state of Pará between the years 2018 and 2023. This analysis considered metropolitan region, age group, sex, self-reported race/skin color and education level. Results: The data analysis recorded a total of 2,189 deaths during the analyzed period, with the highest concentration in the Metropolitan Region of Belém (1,219 deaths; 55.7%), and the capital accounting for an average of 40% of annual cases. Most deaths occurred in women (2,167; 98.9%), in individuals over 40 years old (90.7%) and people of mixed race (pardo) representing 71%. Regarding education, the majority of deaths was among those with 8 to 11 years of schooling (34%). The data also show a year-on-year increase in mortality (an average of 2%), except in 2019, which registered a 4% decrease compared to 2018. Conclusion: The data reveal that mortality due to malignant breast neoplasms in the state of Pará between 2018 and 2023 presents an epidemiological profile marked by a concentration of cases in the Metropolitan Region of Belém, particularly in the capital, which acts as an oncology treatment hub in the region, indicating regional disparities in health care access. The predominance of deaths among women, over 40 years old individuals, pardos and people with intermediate levels of education points to the need for effective and targeted public policies aimed at vulnerable groups. The continuous, albeit moderate, increase in deaths reinforces the urgency of implementing early diagnosis initiatives, expanded mammography coverage and improved comprehensive healthcare in the state. Thus, this epidemiological profile offers valuable insights into the dynamics of breast cancer mortality in the region and may support more effective measures to combat this neoplasm.
It is with great enthusiasm that we present the Annals of the Oncology International Symposium 2025, an event that continues to solidify its significance in the oncology landscape of northern Brazil. Held in Belém, Pará, Oncology 2025 centered around the theme "The cancer control challenge: better knowing it to best facing it," dedicating itself to exploring the latest frontiers in cancer treatment and prevention.
This year, the symposium provided a deep dive into the essential role of knowledge in the fight against cancer, presenting new perspectives and scientific advancements across various areas of oncology. Renowned global experts gathered to share their most recent research and innovative approaches, offering participants a comprehensive view of the challenges faced by healthcare professionals and patients worldwide.
Presentations and discussions during the event focused on critical topics such as the use of new technologies, advancements in personalized therapies, and more effective prevention strategies. Additionally, particular attention was given to the unique challenges faced by the Amazon region, with efforts aimed at developing region-specific solutions to meet local needs.
Beyond being a high-caliber academic event, Oncology 2025 stood out as a moment for integration and professional networking, with the warm hospitality of the city of Belém offering participants a unique experience. This event became a platform for exchanging ideas, where science, culture, and humanity came together in pursuit of a common goal: to improve cancer control both in Brazil and globally.
This collection of abstracts and articles presented during the event reflects the ongoing dedication to research and the development of innovative solutions, highlighting the importance of collaboration and shared knowledge in the fight against cancer.
General Submission Guidelines:
The presenting author, who does not have to be the first author, must be registered for Oncology 2025.
Each abstract may have up to 10 authors, including the main author and co-authors.
Only original, unpublished work will be accepted.
Submissions must be related to oncology. However, project descriptions, work proposals, experience reports, and literature reviews will not be considered.
Clinical case reports are allowed, provided the abstract addresses scientific questions, details clinical observations, and includes primary scientific data.
The abstract must be written in English, but presentations may be given in Portuguese.
Abstracts must be between 300 and 500 words.
Comissão Organizadora
Comissão Científica
See Annals of Oncology 2023 at:
https://www.even3.com.br/anais/oncology-2023-international-symposium/
Complete tool for submission, evaluation and publication of proceedings for scientific events.
